|
|
48Ron Waksman Key Opinion Leader In [Ron Waksman is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 1Recurrence | 1Beta Rays | 1Saphenous Vein | 1Graft Occlusion, Vascular | 1Brachytherapy | 1Coronary Restenosis | 1Vascular Patency | 1Iridium Radioisotopes | 2Gamma Rays | 2Follow-Up Studies | 2Coronary Stenosis | 3Treatment Outcome | 3Coronary Angiography | 4Tunica Intima | 4Coronary Disease | 4Stents | 4Angioplasty, Transluminal, Percutaneous Coronary | 5Coronary Vessels | 5Retrospective Studies | 7Ultrasonography, Interventional | 12Male | 13Predictive Value of Tests | 22Female | 23Middle Aged | 25Aged | 35Humans | 39Coronary Artery Bypass | 48Time Factors | 78Postoperative Complications | 83Myocardial Infarction | 213Risk Factors
Keywords (32) [keywords assigned to Ron Waksman articles by PubMed, the leading number and the color conveys importance]- 43Humans | 35Male | 31Female | 27Middle Aged | 25Stents | 23Brachytherapy | 23Coronary Restenosis | 22Aged | 20Coronary Angiography | 20Treatment Outcome | 16Angioplasty, Transluminal, Percutaneous Coronary | 14Ultrasonography, Interventional | 13Follow-Up Studies | 11Graft Occlusion, Vascular | 11Coronary Vessels | 10Coronary Disease | 10Retrospective Studies | 8Animals | 7Recurrence | 7Coronary Stenosis | 6Myocardial Infarction | 6Predictive Value of Tests | 6Saphenous Vein | 6Time Factors | 6Risk Factors | 6Beta Rays | 6Tunica Intima | 5Vascular Patency | 5Gamma Rays | 5Coronary Artery Bypass | 5Iridium Radioisotopes | 4Postoperative Complications
Other [context-specific ads]Ron Waksman Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Ron Waksman might be a good expert witness on these terms]- 52patients | 48radiation | 45restenosis | 42in-stent | 38coronary | 25therapy | 25lesions | 25intravascular | 24percutaneous | 24plaque | 23clinical | 22brachytherapy | 21late | 20arteries | 20isr | 20intervention | 19beta | 19intracoronary | 18myocardial | 18treatment | 18months | 17angiographic | 17treated | 17results | 17lesion | 17vbt | 16vs | 16gamma | 15acute | 14saphenous | 14thrombosis | 14vein
- 33in-stent restenosis | 18percutaneous coronary | 17intracoronary radiation | 14coronary intervention | 14saphenous vein | 14radiation therapy | 14intravascular ultrasound | 12late thrombosis | 10myocardial infarction | 10vascular brachytherapy | 10intimal hyperplasia | 9additional stents | 9atherosclerotic plaque | 8vein graft | 8in-stent restenotic | 8treatment in-stent | 7clinical angiographic | 7coronary artery | 7radiation in-stent | 7native coronary | 7edge effect | 7de novo | 7restenotic lesions | 6vein grafts | 6angiographic outcomes | 6antiplatelet therapy | 6intravascular radiation | 6bone marrow | 6vulnerable plaque | 5treatment isr | 5gamma radiation | 5patients failed
- 14percutaneous coronary intervention | 9intracoronary radiation therapy | 8saphenous vein graft | 8treatment in-stent restenosis | 7radiation in-stent restenosis | 7in-stent restenotic lesions | 6saphenous vein grafts | 6intravascular ultrasound study | 5coronary intervention saphenous | 5intervention saphenous vein | 4treated additional stents | 4failed intracoronary radiation | 4prolonged antiplatelet therapy | 4intravascular radiation therapy | 4volumetric intravascular ultrasound | 4in-stent restenosis patients | 4recurrent in-stent restenosis | 4acute myocardial infarction | 4radiation recurrent in-stent | 4restenosis patients failed | 4clinical angiographic outcomes | 3coronary intervention patients | 3adverse cardiac events | 3in-stent restenosis trial | 3vulnerable plaque model | 3native coronary arteries | 3therapy in-stent restenosis | 3patients in-stent restenosis | 3coronary artery disease | 3ostial in-stent restenotic | 3fed cholesterol diet | 3mm vs mm
|
|